Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2002-08-05
2008-03-18
Rao, Manjuanth N. (Department: 1647)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S071100, C435S320100, C435S069100, C435S471000, C536S023500, C530S351000
Reexamination Certificate
active
07344880
ABSTRACT:
The present invention relates to compositions containing novel proteins and methods of using those compositions for the diagnosis and treatment of immune related diseases.
REFERENCES:
patent: 4456550 (1984-06-01), Dvorak et al.
patent: 5240848 (1993-08-01), Keck et al.
patent: 5518999 (1996-05-01), Nakamura et al.
patent: 6410708 (2002-06-01), Ashkenazi et al.
patent: WO 98/58061 (1998-12-01), None
patent: WO99/55868 (1999-04-01), None
patent: WO 200070042 (2000-11-01), None
patent: WO 01/53455 (2001-07-01), None
patent: WO 01/98471 (2001-12-01), None
patent: WO 200198471 (2001-12-01), None
M.D. Barratt, Quantitative Structure-Activity Relationships for Skin Permeability; Toxicology In Vitro, vol. 9, No. 1, pp. 27-37, 1995.
Roberts et al. Journal of Cell Science, vol. 108, pp. 2369-2379, 1995.
Bagnato et al, American journal of Pathology, vol. 158, No. 3, Mar. 2001, pp. 841-847.
James A. Wells. Biochemistry, Sep. 18, 1990. vol. 29, No. 37, pp. 8509-8517.
Alderson et al., “Molecular and Biological Characterization of Human 4-1BB and Its Ligand.”European Journal of Immunology. 24(9):2219-2227 (Sep. 1994).
Bolton, C., “Recent Advances in the Pharmacological Control of Experimental Allergic Encephalomyelitis (EAE) and the Implications for Multiple Sclerosis Treatment.”Multiple Sclerosis. 1:143-149 (1995).
Chambers and Allison., “Co-Stimulation in T Cell Responses.”Current Opinion in Immunology. 9(3):396-404 (Jun. 1997).
Coligan et al, eds., “Proliferative Assays for T Cell Function”Current Protocols in Immunology, John Wiley & Sons, Inc., Chapter 3.12, vol. 1 (1994).
Coligan et al., eds.Current Protocols in Immunology., New York:John Wiley & Sons, Inc., Chapter 15.1, 15.2, (1994).
Coligan et al., eds., “Delayed-Type Hypersensitivity.”Current Protocols in Immunology., New York:John Wiley & Sons, Inc., Chapter 4.5, (1994).
Grabbe and Schwarz., “Immunoregulatory Mechanisms Involved in Elicitation of Allergic Contact Hypersensitivity.”Immun. Today. 19(1):37-44 (1998).
Hellstrom and Hellstrom., “T Cell Immunity to Tumor Antigens.”Critical Reviews in Immunology. 18(1-2):1-6 (1998).
Issekutz et al., “Treatment of Established Adjuvant Arthritis in Rats with Monoclonal Antibody to CD18 and Very Late Activation Antigen-4 Integrins Suppresses Neutrophil and T-Lymphocyte Migration to the Joints and Improves Clinical Disease.”Immunology. 88:569-576 (1996).
Jenkins, M., “The Ups and Downs of T Cell Costimulation.”Immunity. 1(6):443-446 (Sep. 1994).
June et al., “The B7 and CD28 Receptor Families.”Immunology Today. 15(7):321-331 (Jul. 1994).
Linsley and Ledbetter., “The Role of the CD28 Receptor During T Cell Responses to Antigen.”Annu. Rev. Immunol. 11:191-212 (1993).
Schwartz, R., “Costimulation of T Lymphocytes: The Role of CD28, CTLA-4, and B7/BB1 in Interleukin-2 Production and Immunotherapy.”Cell. 71(7):1065-1068 (Dec. 24, 1992).
Tanabe et al., “Combined Immunosuppressive Therapy with Low Dose FK506 and Antimetabolites in Rat Allogeneic Heart Transplantation.”Transplantation. 58(1):23-27 (1994).
Tinubu et al., “Humanized Antibody Directed to the IL-2 Receptor β-Chain Prolongs Primate Cardiac Allograft Survival.”J. Immunol. 153:4330-4338 (1994).
Walunas et al., “CTLA-4 Can Function as a Negative Regulator of T Cell Activation.”Immunity. 1(5):405-413 (Aug. 1994).
Wolyniec et al., “Reduction of Antigen-Induced Airway Hyperreactivity and Eosinophilia in ICAM-1-Deficient Mice.”Am. J. Respir. Cell Mol. Biol. 18:777-785 (1998).
Buckley et al., “Plasma Cell Membrane Glycoprotein PC-1”Journal of Biological Chemistry265(29):17506-17511 (1990).
Clark et al., “The Secreted Protein Discovery Initiative (SPDI) , a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment”Genome Research, XP001189293, Cold Spring Harbor Laboratory Press vol. 13:2265-2270 (2003).
DATABASE EMBL, “wal5g01.x1 NCI—CGAP—Kid11Homo sapienscDNA clone IMAGE:2298192 3′similar to contains TAR1.t2 TAR1 repetitive element : mRNA sequence.”NCI-CGAP, Database accession No. AI640575 vol. XP002297353 (Apr. 29, 1999).
DATABASE NCBI; Clark et al., “Homo sapiensclone DNA108700 RGLA3077 (UNQ3077) mRNA, complete cds.”Database accession No. AY358622, XP002297354 (Oct. 3, 2003).
Duan et al., “Identification of Human Intestinal Alkaline Sphigomyelinase as a Novel Ecto-enzyme Related to the Nucleotide Phosphodiesterase Family”Journal of Biological Chemistry278(40):38528-38536 (2003).
Jin-Hua et al., “Molecular Cloning and Chromosomal Localization of PD-Iβ (PDNP3) , a New Member of the Human Phosphodiesterase I Genes”Genomics, XP004434160, San Diego:Academic Press vol. 45(2):412-415 (Oct. 15, 1997).
Janeway, C., et al.,Immo Biology(5thed ) In Chapter 12:Allergy and Hypersensitivity, Section 12-9—pp. 484-485 (2001).
McDyer, et al., “Patients with Multidrug-Resistant Tuberculosis with Low CD4+ T Cell Counts Have Impaired Th1 Responses,”The Journal of Immunology, vol. 158, pp. 492-500 (1997).
McElrath, et al., “Cutaneous Response to Recombinant Interleukin 2 in Human Immunodeficiency Virus 1-Seropositive Individuals,”Proc. Natl. Acad. Sci, USA, vol. 87, pp. 5783-5787 (1990).
Rampart, et al., “Granulocyte Chemotactic Protein/Interleukin-8 Induces Plasma Leakage and Neurtophil Accumulation in Rabbit Skin,”Am J Pathol, vol. 135, pp. 21-25 (1989).
Tyring, S., “Imiquimod Applied Topically: A Novel Response Modifier,”Skin Therapy Letter, 6(6):1-4 (Mar. 2001).
Zaki, et al., “Synergistic Enhancement of Cell-Mediated Immunity by Interleukin-12 Plus Interleukin-2: Basis for therapy of Cutaneous T Cell Lumphoma,”J. Invest. Dermatol., vol. 118, No. 2, pp. 368-371 (Feb. 2002).
Duan, Rui-Dong et al., “Identification of Human Intestinal Alkaline Sphingomyelinase as a Novel Ecto-enzyme Related to the Nucleotide Phosphodiesterase Family”, The Journal of Biological Chemistry, vol. 278, No. 40, Issue of Oct. 3, 2003, pp. 38528-38536.
Wu, Jun et al., “Functional studies of human intestinal alkaline sphingomelinase by deglycosylation and mutagenesis”, Biochem Journal (2005) 386, pp. 153-160.
Duan, Rui-Dong et. al., “Purification, localization and expression of human intestinal alkaline sphingomyelinase”, Journal of Lipid Research, vol. 44, 2003, pp. 1241-1250.
Wu, Jun et. al., “Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells”, Carcinogenesis, vol. 25 No. 8 (2004), pp. 1327-1333.
Fong Sherman
Goddard Audrey
Godowski Paul J.
Grimaldi J. Christopher
Gurney Austin L.
Barnes Elizabeth M.
Dreger Ginger R.
Genentech Inc.
Hamud Fozia M
Kresnak Mark T.
LandOfFree
Nucleic acid encoding PRO9912 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid encoding PRO9912 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid encoding PRO9912 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3969744